OLX-301

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOLX-301
Drug Alias NameOLX-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionConnective tissue growth factor inhibitorsVascular endothelial growth factor inhibitors
TargetsVascular endothelial growth factorConnective tissue growth factor
Therapy Area/IndicationsFibrosisMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOlix Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesOlix Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsFibrosisMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A